| Mr Perry Chet Goldstein, RN, BSN,CMSRN | |
|
647 Us Route 1, #14149, York, ME 03909-1689 | |
| (207) 272-4787 | |
| (207) 221-1273 |
| Full Name | Mr Perry Chet Goldstein |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse - Medical-surgical |
| Location | 647 Us Route 1, York, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043247828 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Perry Chet Goldstein, RN, BSN,CMSRN 647 Us Route 1, #14149, York, ME 03909-1689 Ph: (207) 272-4787 | Mr Perry Chet Goldstein, RN, BSN,CMSRN 647 Us Route 1, #14149, York, ME 03909-1689 Ph: (207) 272-4787 |
News Archive
In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
Workers and residents exposed to dust and fumes caused by the collapse of the World Trade Center on September 11, 2001 frequently reported headache years later, according to research released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that an acute migraine therapy that is not contraindicated in patients with a history, symptoms or signs of vascular disease and also offers improved efficacy and fast-acting oral delivery would earn a 45 percent patient share in the treatment of migraine, according to surveyed U.S. neurologists.
The number of cases of invasive pneumococcal disease (IPD) in children has fallen since the introduction of a new vaccine a year ago. Enhanced surveillance by the UK's Health Protection Agency has shown that cases of IPD caused by the seven major types of the pneumococcus bacteria which the new pneumococcal conjugate vaccine (PCV) protects against have gone down by almost 50%.
› Verified 1 days ago
Kaitlin Ellen Devlin, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 1 Loving Kindness Way, York, ME 03909 Phone: 207-363-4321 | |
Ms. Marjorie Ann Tricca, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Hospital Drive, York Hospital, York, ME 03909 Phone: 207-351-2400 Fax: 207-351-2193 | |
Daniel Layton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Hospital Dr, York, ME 03909 Phone: 207-361-6173 Fax: 207-351-2216 | |
Judith Kathryn Cook, CRNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Hospital Dr, York, ME 03909 Phone: 207-351-2400 |